Tylenol, Vaccines, Autism and Evolutionary Mismatch

This week, the internet is buzzing again. Donald Trump made headlines suggesting Tylenol might be linked to autism. Before that, it was vaccines at the center of the storm.And here’s the funny thing: it almost doesn’t matter which side of this debate you’re on. If you believe the idea that Tylenol or vaccines could cause autism is ridiculous, you’re probably outraged that it’s even being discussed. If you believe the idea might be true, you’re probably outraged that it keeps being dismissed. Either way, the noise is deafening, and the anger is real.That anger, though, may be stopping us from asking a more useful question.Correlation EverywhereOne of the most maddening challenges in human health is the problem of correlation.There are studies that show an association between acetaminophen use in pregnancy and autism. There are studies that suggest children’s vaccination schedules line up with the timing of autism diagnoses. But none of these studies demonstrate causation. The data is messy, contradictory, and confounded by hundreds of other variables—genetics, infections, socioeconomic factors, even differences in how often children are screened and diagnosed.Remember, correlations can be interesting but they have to be watched carefully. When COVID-19 began, maps correlating 5G cellular networks with infections made many people believe there was a causal relationship. To address this, I once produced a map showing the layout of fast-food restaurants, dry cleaners, and banks. Guess what? They also correlated with both 5G rollout and COVID-19 infections.Why? Because all of those things required human population; all of the maps simply reflected where people were. That was it.So maybe we’re asking the wrong questions. Instead of treating Tylenol or vaccines as villains or saviors, maybe we should look for what else they have in common. What are the larger correlations that should be taken into consideration?Fever: A Forgotten CorrelationWhen a child is sick, or when they get a vaccine, the body often responds with a fever. Fever isn’t an accident. It’s an evolved, built-in defense that slows down pathogens and rallies the immune system. Heating the body makes the environment hostile to many pathogens and, at the very least, slows their replication.For most of human history, fever was left to run its course. But modern medicine brought us drugs that could bring fevers down. About 20 years ago, medical guidelines shifted: instead of “fight the fever,” the advice became “fight the discomfort, not the fever.” But in practice, that often still meant suppressing fever—and with it, blocking an important immune function.Perhaps that is what requires a closer look: the act of fighting the fever.Think of it this way: people often develop a fever when a pathogen enters or invades the body—whether that invasion is natural or introduced by a vaccine. If we let the body do its job, the fever might slow the pathogen’s progression and limit the damage it can do. If we suppress it, though, we may be giving pathogens and inflammatory processes more room to operate, right when the developing brain is most sensitive.A Global MapIf we zoom out, we can see cultural patterns.Some countries, like the United States and Canada, have what we might call a 2025-style medical culture: quick to medicate, quick to suppress discomfort, quick to reach for pharmaceutical solutions. Other countries are “earlier on the timeline”—more conservative in prescribing, less reflexive about suppressing fever.Interestingly, when we compare those medical cultures to autism prevalence, we see another pattern: countries that are “further along” in suppressing fevers also tend to be “further along” in reporting or diagnosing autism.This isn’t proof. But it’s a correlation worth noticing.Figure: A metaphorical “global map” comparing medical culture (x-axis) and autism reporting culture (y-axis), with the United States set as 2025. (Full Explanation and sources at the end of the article.)Glutathione: Another Piece of the PuzzleThere’s another layer to this story.The brain depends heavily on glutathione, the body’s master antioxidant. Infections deplete glutathione. Vaccines (by triggering the immune system) may deplete it, too. And acetaminophen—the most common fever-reducing drug—uses up glutathione as part of its metabolism.So imagine the sequence: a child or a pregnant mother gets an infection, their glutathione levels fall, and then acetaminophen is given, depleting glutathione further. At the very time when the developing brain most needs antioxidant protection, the reserves may be lowest.We also know that pathogens themselves can cause neurological harm. Maternal infections during pregnancy have been linked to higher autism risk in children, and animal studies show that maternal immune activation can alter brain development. Viral and bacterial infections, from influenza to meningitis, have been shown to leave lasting neurological scars.So if fever suppression and glutathione depletion allow pathogens to persist longer or multiply more freely, even subtle brain injuries could become more likely.In other words, doesn’t it make sense that when we combine these three factors—Suppressing fever during infection or vaccination,Depleting glutathione at a vulnerable moment, andPathogens capable of neurological harm— we might be creating conditions where subtle, cumulative brain injuries contribute to developmental outcomes?I am not claiming to have the answer—only that we may be asking the wrong questions. Evolutionary mismatch may be at play here; perhaps the real issue isn’t Tylenol or vaccines themselves, but our ability to suppress fever. Of course we want to fight it—to end discomfort. But in doing so, we may be creating unintended consequences, weakening the very defenses that nature designed to protect us.The true correlations may lie not in the easy scapegoats but in how we interfere with the body’s own immune intelligence. For decades, hospitals taught “fight the fever.” Then came “fight the discomfort, not the fever.” Maybe the next step forward is to trust the fever—to support comfort without disabling the mechanism designed to keep us safe.If we could step beyond politics, outrage, and noise, we might finally begin exploring questions that lead us closer to truth.My hope is simple: that this piece has opened a door. The next step is not to close it with certainty, but to walk through it with curiosity.Thanks for reading The Evolution Gap! Subscribe for free to receive new posts and support my work.Further Reading & ReferencesMayo Clinic – Fever in children Practical guidance that fevers in otherwise healthy kids usually don’t need treatment unless they cause discomfort. Supports the idea of comfort-based, not number-based, fever management.Evans et al., 2015 (Nature Reviews Immunology) Comprehensive review showing fever as an integrated host defense—how raising temperature slows pathogens and boosts immune response.Haddad et al., 2023 (eLife) Explores how fever interacts with immune signaling and outcomes, reinforcing that fever is not just a symptom but part of the immune system’s strategy.Prymula et al., 2009 (Lancet) Landmark study showing prophylactic acetaminophen given with vaccines reduced antibody responses—evidence that antipyretic use can blunt immunity.CDC & Pharmacy Times – Vaccine guidance Both highlight that pre-medicating children with fever reducers before vaccination is discouraged, because it may reduce immune response.JAMA Network (2024 sibling-control study) Found no causal link between prenatal acetaminophen and autism once family confounders were accounted for—illustrates the messiness of correlation.WHO, 2025 overview Concluded evidence on acetaminophen in pregnancy and neurodevelopment is inconsistent and inconclusive—again pointing to the need for better studies.Mackowiak et al., 1998 (JAMA) Classic paper arguing fever is an adaptive response that often doesn’t need suppression.Studies on glutathione and acetaminophen metabolism Show that acetaminophen’s toxic metabolite is detoxified by glutathione, explaining why heavy use can deplete reserves and why NAC is the antidote in overdose.Brown et al., 2004 (Am J Psychiatry) Showed maternal infection during pregnancy increases risk of neurodevelopmental disorders in offspring, linking pathogens to brain outcomes.Shi et al., 2005 (J Neurosci) Animal study demonstrating that maternal immune activation alters brain development and behavior in offspring.Atladóttir et al., 2010 (Pediatrics, Denmark cohort) Found maternal infection requiring hospitalization was associated with higher risk of autism in children.Hornig et al., 2018 (Molecular Psychiatry) Review on maternal viral infections and neurodevelopmental disorders, emphasizing immune-driven pathways to subtle brain injury.Williamson et al., 2018 (Nat Rev Neurology) Review showing infections like Zika virus, influenza, and bacterial meningitis can cause direct or indirect neurological damage.Figure: A metaphorical “global map” comparing medical culture (x-axis) and autism reporting culture (y-axis), with the United States set as 2025. Countries further to the “right” represent cultures quicker to medicate and suppress fever; countries higher on the chart represent cultures further along in reporting and diagnosing autism. This is not a prevalence chart but a conceptual illustration of how fever management practices and autism diagnoses may trend together.Sources informing placement:Medical culture & fever suppression:Mayo Clinic – Fever in children: recommends treating for comfort, not for temperature alone.Mackowiak et al., 1998 (JAMA): fever as an adaptive immune response that often should not be suppressed.Evans et al., 2015 (Nat Rev Immunol) and Haddad et al., 2023 (eLife): fever as an integrated immune program.Autism prevalence & reporting culture:Atladóttir et al., 2010 (Pediatrics, Denmark cohort): maternal infection and autism risk; highlights population-level tracking.Brown et al., 2004 (Am J Psychiatry) and Shi et al., 2005 (J Neurosci): infection and immune activation as neurodevelopmental risk factors.WHO and CDC surveillance data (various years): show wide differences in autism prevalence reporting due to diagnostic practices, screening intensity, and services access.